Evaluation of Nurse Preferences Between the Lanreotide Autogel New Syringe and the Octreotide Long-Acting Release Syringe: An International Simulated-Use Study (PRESTO)
ConclusionsNurses preferred the user experience of the LAN new syringe compared with the octreotide LAR syringe, with a particular preference for attributes related to product delivery with the LAN new syringe.Graphical Abstract
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Acromegaly | Brain | Cancer & Oncology | Carcinoid Tumor | Drugs & Pharmacology | Hormones | Neurology | Nurses | Nursing | Pituitary Tumor | Study